SEC Form N-PORT · 2026-03-31
HELX ETF Holdings
Franklin Genomic Advancements ETF reported 61 holdings. Weights reproduce the source and may not sum to exactly 100 because of cash, derivatives, rounding, liabilities, or other positions.
- Report date
- 2026-03-31
- SEC accession
- 0000940400-26-020149
- Series ID
- S000067393
- Source
- SEC Form N-PORT
All reported holdings
| Ticker | Issuer | Weight | Value (USD) | Balance |
|---|---|---|---|---|
| GH | Guardant Health Inc | 6.769554% | 1,451,871.66 | 15,718 NS |
| NTRA | NATERA INC | 6.649524% | 1,426,128.69 | 7,131 NS |
| KRYS | Krystal Biotech Inc | 5.321273% | 1,141,257.76 | 4,418 NS |
| UTHR | United Therapeutics Corporation | 4.644951% | 996,206.4 | 1,680 NS |
| INSM | Insmed Inc | 4.522763% | 970,000.64 | 5,932 NS |
| BBIO | Bridgebio Pharma Inc | 4.221451% | 905,377.92 | 12,192 NS |
| LGND | Ligand Pharmaceuticals Incorporated | 3.531819% | 757,472.1 | 3,794 NS |
| AZN | AstraZeneca PLC | 3.397795% | 728,727.9 | 3,695 NS |
| ADPT | Adaptive Biotechnologies Corp | 3.122293% | 669,640.6 | 48,245 NS |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.987749% | 640,784.9 | 1,435 NS |
| 207940 | Samsung Biologics Co Ltd | 2.985161% | 640,229.82 | 652 NS |
| MEDP | Medpace Holdings Inc. | 2.97109% | 637,212.13 | 1,327 NS |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.694701% | 577,934.72 | 748 NS |
| CTVA | Corteva Inc | 2.694697% | 577,933.84 | 6,904 NS |
| ALNY | Alnylam Pharmaceuticals Inc. | 2.602581% | 558,177.69 | 1,687 NS |
| LLY | Eli Lilly & Co. | 2.543114% | 545,423.61 | 593 NS |
| IONS | Ionis Pharmaceuticals, Inc. | 2.085651% | 447,311.13 | 5,957 NS |
| TEM | Tempus AI Inc. | 1.83983% | 394,589.72 | 8,726 NS |
| BNTX | BioNTech SE | 1.798563% | 385,739.2 | 4,340 NS |
| NBIX | Neurocrine Biosciences Inc | 1.654192% | 354,775.82 | 2,693 NS |
| STOK | Stoke Therapeutics Inc | 1.599984% | 343,149.84 | 10,539 NS |
| TWST | Twist Bioscience Corporation | 1.591749% | 341,383.68 | 7,184 NS |
| ARGX | Argenx SE | 1.53082% | 328,316.12 | 459 NS |
| PTCT | PTC Therapeutics, Inc. | 1.47778% | 316,940.76 | 4,652 NS |
| TVTX | Travere Therapeutics Inc | 1.40314% | 300,932.59 | 10,129 NS |
| CRL | Charles River Laboratories International, Inc. | 1.162221% | 249,262.5 | 1,445 NS |
| CRSP | CRISPR Therapeutics AG | 1.036036% | 222,199.47 | 4,671 NS |
| RGEN | Repligen Corporation | 1.025091% | 219,852.12 | 1,866 NS |
| VCYT | Veracyte Inc | 1.019446% | 218,641.48 | 6,788 NS |
| PRAX | Praxis Precision Medicines Inc | 1.002005% | 214,900.73 | 667 NS |
| GRAL | GRAIL Inc | 0.997114% | 213,851.84 | 4,138 NS |
| SRT3 | Sartorius AG | 0.957385% | 205,331.11 | 841 NS |
| DHR | Danaher Corporation | 0.928238% | 199,080 | 1,050 NS |
| TMO | Thermo Fisher Scientific Inc | 0.896104% | 192,188.23 | 391 NS |
| IQV | IQVIA Holdings Inc. | 0.799142% | 171,392.7 | 1,005 NS |
| BEAM | BEAM THERAPEUTICS INC | 0.781775% | 167,667.88 | 7,036 NS |
| JAZZ | Jazz Pharmaceuticals PLC | 0.741318% | 158,991.05 | 841 NS |
| CPRX | Catalyst Pharmaceuticals Inc. | 0.735974% | 157,845 | 6,375 NS |
| CDNS | Cadence Design Systems, Inc. | 0.706106% | 151,439.15 | 545 NS |
| A | Agilent Technologies Inc. | 0.603725% | 129,481.28 | 1,136 NS |
| CDNA | Caredx Inc | 0.601329% | 128,967.44 | 7,429 NS |
| QGEN | QIAGEN NV | 0.592747% | 127,127 | 3,175 NS |
| ANAB | AnaptysBio Inc. | 0.527782% | 113,193.86 | 2,041 NS |
| 0126Z0 | SAMSUNG EPIS HOLDINGS CO LTD | 0.526341% | 112,884.8 | 350 NS |
| TARS | Tarsus Pharmaceuticals Inc | 0.486374% | 104,313.05 | 1,487 NS |
| RARE | Ultragenyx Pharmaceuticals Inc | 0.465456% | 99,826.75 | 4,765 NS |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 0.451161% | 96,760.92 | 4,107 NS |
| AXSM | Axsome Therapeutics Inc. | 0.446053% | 95,665.32 | 566 NS |
| WGS | GeneDx Holdings Corp | 0.421903% | 90,485.98 | 1,409 NS |
| RYTM | Rhythm Pharmaceuticals Inc | 0.394966% | 84,708.78 | 974 NS |
| HNGE | HINGE HEALTH INC | 0.392305% | 84,137.92 | 2,182 NS |
| BMY | Bristol-Myers Squibb Company | 0.314179% | 67,382.15 | 1,111 NS |
| BIO | Bio-Rad Laboratories, Inc. | 0.293735% | 62,997.5 | 226 NS |
| ONC | BEONE MEDICINES LTD | 0.289395% | 62,066.73 | 209 NS |
| TMDX | TransMedics Group Inc. | 0.223413% | 47,915.62 | 482 NS |
| NGNE | Neurogene Inc. | 0.172958% | 37,094.4 | 1,840 NS |
| WVE | Wave Life Sciences Ltd. | 0.151104% | 32,407.5 | 4,470 NS |
| RXRX | Recursion Pharmaceuticals Inc | 0.148769% | 31,906.51 | 10,393 NS |
| CAI | Caris Life Sciences Inc. | 0.046436% | 9,959.16 | 557 NS |
| 2200963D | OMNIAB INC | 0% | 0 | 240 NS |
| 2200964D | OMNIAB INC | 0% | 0 | 240 NS |